December 13, 2023
Merdury BioPharmaceutical Inc And Shiner Pharm Corp Sign Technology Platform Licensing Agreement
Merdury BioPharmaceutical's New Drug Development Technology Platform Stackdose™ Enters UBI Pharma's PIC/S GMP Facility
Merdury BioPharmaceutical's Sildenafil Development Results Published in International Journal Life
July 28, 2024
Merdury signs MOU with Health2Sync to conduct trial of Merdury’s StackDose technology intended for usage in GLP-1 (semaglutide) medication
